The discussion was on Tuesday, December 7, 2021
Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy Monitoring
Speaker –
Giampaolo Bianchini, MD
Speaks about Harnessing the TNBC Microenvironment to Integrate Novel Predictive Biomarkers